C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the gene encoding for huntingtin protein. A lot has been learned about this …
AG Kazantsev, LM Thompson - Nature reviews Drug discovery, 2008 - nature.com
Histone deacetylases (HDACs)—enzymes that affect the acetylation status of histones and other important cellular proteins—have been recognized as potentially useful therapeutic …
Cholesterol is a major constituent of the human brain, and the brain is the most cholesterol‐ rich organ. Numerous lipoprotein receptors and apolipoproteins are expressed in the brain …
JMM van der Burg, M Björkqvist, P Brundin - The Lancet Neurology, 2009 - thelancet.com
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic …
R Luthi-Carter, DM Taylor, J Pallos… - Proceedings of the …, 2010 - National Acad Sciences
Huntington's disease (HD), an incurable neurodegenerative disorder, has a complex pathogenesis including protein aggregation and the dysregulation of neuronal transcription …
J Schulte, JT Littleton - Current trends in neurology, 2011 - ncbi.nlm.nih.gov
Huntington's Disease is an adult-onset dominant heritable disorder characterized by progressive psychiatric disruption, cognitive deficits, and loss of motor coordination. It is …
C Vitali, CL Wellington, L Calabresi - Cardiovascular research, 2014 - academic.oup.com
Cholesterol is an essential component of both the peripheral nervous system and central nervous system (CNS) of mammals. Brain cholesterol is synthesized in situ by astrocytes …
L Boussicault, S Alves, A Lamazière, A Planques… - Brain, 2016 - academic.oup.com
Huntington's disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of …
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S …